Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related

Chiara Foglieni1, Stéphanie Papin1, Agnese Salvadè1

  • 1Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Torricella-Taverne, Switzerland.

Scientific Reports
|October 27, 2017
PubMed
Summary

Protein multimerization is key in neurodegenerative diseases. This study uses split GFP technologies to analyze TDP-43 oligomerization, revealing structural factors critical for understanding frontotemporal dementia and ALS.